By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Schneider Shorts 15.04.2022 – a resurrected career of a French biologist, a Spanish martyr saint takes revenge on two more apostate sinners, a limitless indulgence for sins past, present and future for a cancer cheater in Texas, Elsevier’s half-hearted exorcism of a Greek antivaxxer, papers to get rid of, and a self-righteous Italian diva in Zürich waving another sockpuppet.
“In October of this year, the scientist who closed the American laboratory, disposed of related assets in the United States, and returned to Shanghai with his wife to start a business, officially opened the mode of “wholeheartedly” returning to his country to start a business.”
Schneider Shorts 22.10.2021: acupuncture in Nature, creationism in Scientific American, proxalutamide scandal reaches Brazilian Senate, a surprise new US academy member, entirely valid conclusions of photoshop fraud, MDPI reaches level X, colchicine doesn’t work for COVID-19 but fake Russian statistics do, plus Russian paper mills and a stuck Sputnik V.
Schneider Shorts 5.08.2021: ivermectin-flavoured cigarettes, homeopathy, Ayurveda, and the scientists I have harassed in the past, the present and plan to harass in the future.
“IU School of Medicine scientists discover ‘game-changer’ treatment for triple negative breast cancer”
The new ERC President Mauro Ferrari used to closely collaborate with two very controversial cancer researchers at MD Anderson in Texas: Anil Sood and Gabriel Lopez-Beerestein. Will that experience affect ERC’s already wanting stance on research integrity?
My earlier article presented the worrisome research integrity record at the gigantic US cancer research hospital MD Anderson Cancer Center, partContinue Reading
The MD Anderson Cancer Center, part of the University of Texas and located in Houston, is a giant hub ofContinue Reading
For Better Science